Two Sigma Advisers »

Leap Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $45k 100k 0.45
2025-06-30 $12k 41k 0.30

More positions owned by Two Sigma Advisers

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Meta Platforms Cl A (META)
Bank of America Corporation (BAC)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Lockheed Martin Corporation (LMT)
Intuitive Surgical Com New (ISRG)
Adobe Systems Incorporated (ADBE)
Charles Schwab Corporation (SCHW)

View all positions for Two Sigma Advisers

Top funds holding Leap Therapeutics

Gilead Sciences
Acadian Asset Management
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
Key Client Fiduciary Advisors
State Street Corporation
BlackRock
Hrt Financial
Two Sigma Advisers
Susquehanna International
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics